Inventor · disambiguated record
Nabil Farah
Also filed as: FARAH NABIL
6 granted patents·2 pending applications·441 citations·filing 1997–2017
87Inventor score
Technology areasA61K
Top patents by PatentIndex Score
8 records- 0195US6375987B1Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrixGATTEFOSSE ETS SA·Filed 2000·Granted Apr 23, 2002·136 cites·4 claims
- 0292US6054136AOrally administrable composition capable of providing enhanced bioavailability when ingestedGATTEFOSSE ETS SA·Filed 1997·Granted Apr 25, 2000·138 cites·18 claims
- 0391US6312704B1Orally administrable composition capable of providing enhanced bioavailability when ingestedGATTEFOSSE ETS SA·Filed 2000·Granted Nov 6, 2001·46 cites·26 claims
- 0490US6379700B2Process for manufacturing tablets for the sustained release of active principle(s)GATTEFOSSE ETS SA·Filed 2000·Granted Apr 30, 2002·75 cites·12 claims
- 0573US6194005B1Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrixGATTEFOSSE ETS SA·Filed 1997·Granted Feb 27, 2001·46 cites·18 claims
- 0645US2002142037A1Process for the manufacture of a pharmaceutical composition with modified release of active principle comprising a matrixFiled 2002·Application pending·0 cites
- 0744US2003021844A1Immediate-release oral pellet comprising polyglycolysed glycerides, and manufacturing processFiled 2002·Application pending·0 cites
- 0826US10952966B2Pharmaceutical composition comprising solid dispersion of BCS class II drugs with GeluciresGATTEFOSSE INDIA PVT LTD·Filed 2017·Granted Mar 23, 2021·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Nabil Farah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →